Homepage
Medication Guide
How much is the price of Fyarro?
Fyarro is a drug for the treatment of advanced renal cell carcinoma and has received widespread attention worldwide. Its price, purchase channels and storage methods are the focus of patients and...
509
Monday, July 28th, 2025, 16:07
Efficacy of palbociclib combined with Fulvestrant in the treatment of advanced breast cancer
A prospective, international, randomized, double-blind, placebo-controlled phase 3 trial studied the efficacy of palbociclib + Fulvestrant and placebo + Fulvestrant in patients with hormone ...
507
Monday, July 28th, 2025, 15:50
Faslodex(Fulvestrant): Treatment Effect, Symptom Relief, Clinical Outcome
Palbociclib (Ibrance®) is an oral, reversible, selective, small molecule inhibitor of cyclin-dependent kinase (CDK) 4 and CDK6, developed by Pfizer for the treatment of cancer. CDKs are important regu...
505
Monday, July 28th, 2025, 15:37
Comparison of clinical efficacy of Fulvestrant and anastrozol
A randomized, double-blind, double-dummy, multicenter study (FALCON, NCT01602380) was conducted in postmenopausal patients with locally advanced or metastatic breast cancer who were ER-positive and/or...
508
Monday, July 28th, 2025, 15:12
Instructions for use of Fulvestrant
Fulvestrant is a prescription injection used to treat certain hormone receptor-positive conditions. Understanding how to use it correctly is important for effective treatment. This article provides cl...
509
Monday, July 28th, 2025, 14:52
New treatment option! Capivasertib combined with Fulvestrant
AstraZeneca announced on June 12, 2023 that the U.S. FDA has agreed to prioritize the review of the new drug application for Capivasertib combined with Fulvestrant for the treatment of adult pati...
508
Monday, July 28th, 2025, 14:31
Apellis-Fulvestrant treatment of breast cancer to prolong PFS?
Advanced breast cancer is generally considered an incurable cancer, but it can still be treated to relieve symptoms, control the progression of cancer, prolong the patient's survival time and impr...
504
Monday, July 28th, 2025, 14:22
How effective is apelisib combined with Fulvestrant in treating breast cancer?
Studies have shown that inhibition of PI3K by Apellis treatment can induce increased transcription of the estrogen receptor (ER) in breast cancer cells. In xenograft models of ER-positive, PIK3CA-muta...
508
Monday, July 28th, 2025, 13:56
Reblozyl instructions
Luspatercept (REBLOZYL), developed by Bristol-Myers Squibb, has been approved for marketing in many countries for the treatment of adult patients with β-thalassemia who require regular red blood cell ...
502
Friday, July 25th, 2025, 17:16
Clinical trial efficacy of Reblozyl
Reblozyl is a recombinant fusion protein that binds to multiple endogenous TGF-β superfamily ligands, thereby reducing Smad2/3 signaling. Reblozyl promotes erythrocyte maturation by differen...
504
Friday, July 25th, 2025, 17:08
148 / 208
2071 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved